Pfizer’s Covid pill breakthrough
After the UK medicines regulator yesterday approved Merck’s Covid pill for use on recently infected, vulnerable patients, Pfizer announced its own successful treatment, Paxlovid. Pfizer’s pill was shown to reduce the risk of hospitalisation and death in Covid patients by up to 89 per cent compared with a placebo. The drug has proved so effective
